SCHEMBL3285657

SCHEMBL3285657

CCOC(=O)C(C)(CC(=O)Oc1ccc(CC)c(CC)c1)C(=O)OCC

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 2/20 0.41
ABCB11 O95342 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
HTR2A P28223 1/20 0.41
PMP22 Q01453 1/20 0.41
MMP8 P22894 2/20 0.39
ACHE P22303 1/20 0.38
ALDH1A1 P00352 2/20 0.36
OPRK1 P41145 1/20 0.36
FBP1 P09467 4/20 0.36
NPC1 O15118 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LMNA P02545 1/20 0.34
PIN1 Q13526 1/20 0.34
KDM4E B2RXH2 1/20 0.34
PPARG P37231 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1076676 0.72 GAA (0.48) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL4793276 0.69 PPARA (0.52) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL3282520 0.67 PTPRB (0.41) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL6036068 0.67 PPARA (0.60) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL15580691 0.66 PPARA (0.67) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL14280523 0.65 MMP8 (0.47) PPARAABCB11CYP1A2CYP3A4TSHR
SCHEMBL7083444 0.65 NQO1 (0.56) CYP1A2CYP3A4TSHRALDH1A1NPC1
SCHEMBL19335474 0.65 ELANE (0.54)
SCHEMBL19335346 0.65 ELANE (0.53)
SCHEMBL3278579 0.65 ALDH1A1 (0.49) PPARACYP1A2TSHRMMP8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152171-A1 CGRP Antagonists BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2010-06-17 US disclosed
US-7700589-B2 CGRP antagonists BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2010-04-20 US disclosed
US-20070244099-A1 CGRP Antagonists RUDOLF KLAUS 2007-10-18 US disclosed
US-20040132716-A1 CGRP antagonists BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244099-A1 CGRP Antagonists CALCRL, OPRL1, CALCA PPARA 1550/4885ABCB11 3553/4885CYP1A2 1977/4885
US-20100152171-A1 CGRP Antagonists CALCRL, OPRL1, CALCA PPARA 1550/4885ABCB11 3553/4885CYP1A2 1977/4885
US-20040132716-A1 CGRP antagonists OPRL1, HTR1D, CALCA PPARA 2442/4885ABCB11 3506/4885CYP1A2 2212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.